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Prevalence of Diabetes in U.S.
Youth in 2009: The SEARCH for
Diabetes in Youth Study
OBJECTIVE
To estimate the prevalence of diabetes in U.S. youth aged,20 years in 2009 and
to estimate the total number of youth with diabetes in the U.S. by age, race/
ethnicity, and diabetes type.
RESEARCH DESIGN AND METHODS
To address one of its primary aims, the SEARCH for Diabetes in Youth Study
identified youth aged,20 years on 31 December 2009 with physician-diagnosed
diabetes in selected areas of Colorado, Ohio, South Carolina, and Washington,
among health plan members of Kaiser Permanente Southern California and
among American Indians living on reservations in Arizona and New Mexico. Di-
abetes was classified as type 1, type 2, or other. Race/ethnicity was by self-report.
RESULTS
From a population of 3,458,974 youth aged,20 years, 7,695 youth with diabetes
were identified (2.22/1,000): 6,668 with type 1 diabetes (1.93/1,000), 837 with
type 2 diabetes (0.24/1,000), and 190 (0.05/1,000) with other diabetes types.
Prevalence increased with age, was slightly higher in females than males, and was
most prevalent in non-Hispanic White and least prevalent in Asian/Pacific
Islanders, with Native American and black youth having the highest prevalence of
type 2 diabetes. An estimated 191,986 U.S. youth aged,20 years have diabetes;
166,984 type 1 diabetes, 20,262 type 2 diabetes, and 4,740 other types.
CONCLUSIONS
Diabetes, one of the leading chronic diseases in childhood, affects >190,000 (1 of
433) youth aged ,20 years in the U.S., with racial and ethnic disparities seen in
diabetes prevalence, overall and by diabetes type.
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Diabetes is the third most common chronic disease of childhood (1), and its
incidence has been increasing worldwide (2,3). Diabetes in children and adolescents
is a set of complex disorders with heterogeneity in etiology, pathogenesis, clinical
presentation, and outcomes. Type 1 diabetes is caused by immune-mediated b-cell
destruction, leading to insulin deficiency and a lifelong insulin requirement, while
type 2 diabetes is characterized by insulin resistance in skeletal muscle, liver, and
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adipose tissues with a failure of b-cell
compensation and a relative insulin
deficiency (4). The occurrence of type 2
diabetes in youth has been documented
in several studies over the past decade
(5–7) and is thought to be secondary to
coincident increases in obesity in the
general population. In addition, there
are multiple less common types of
diabetes in youth such as monogenic
forms, including maturity-onset
diabetes in the young, neonatal
diabetes, and other known genetic
disorders (8,9).
There are few recent studies of the
prevalence of diabetes in youth in the
U.S. by diabetes type. Most of the prior
registries active in the U.S. were initially
focused on type 1 diabetes (10,11) and
have only recently begun to include type
2 diabetes (12,13). The SEARCH for
Diabetes in Youth Study (SEARCH), with
centers located in multiple states across
the U.S. (14), was developed to assess
the prevalence and incidence of
diabetes in youth, overall and by type.
Surveillance of youth with diabetes
began in 2001 and is ongoing for
incident case ascertainment, while
prevalence surveillance was conducted
for calendar years 2001, which was
published previously (15), and 2009. The
purposes of this article are to report the
prevalence of diabetes in 2009, overall
and by diabetes type, age, sex, and race/
ethnicity, and to apply these estimates
to U.S. census data for youth aged ,20
years to estimate the total burden
(absolute number) of youth with
diabetes in the U.S. in 2009.
RESEARCH DESIGN AND METHODS
A detailed description of SEARCH was
published previously (14). Physician-
diagnosed diabetes was identified in five
SEARCH sites in California, Colorado,
Ohio, South Carolina, and Washington.
Four of these sites were geographically
based; Colorado (14 counties), Ohio
(8 counties), South Carolina (4 counties),
and Washington (5 counties). The
California site comprised health plan
enrollees in Kaiser Permanente
Southern California (KPSC; seven
counties). Coordinated by the Colorado
site, SEARCH also collected data from
American Indians on selected
reservations in Arizona and New
Mexico. All centers had active
surveillance by endocrinologists
(pediatric and adult), other health care
providers, hospitals, community health
centers, health plan databases, and
previously established diabetes
databases. The Indian Health Service
(IHS) beneficiary roll was used to
identify the reservation-based American
Indian youth. Two-source capture-
recapture in the geographically based
centers was used to estimate the
completeness of case identification
(16,17). Capture-recapture was not
conducted for the membership-based
center because the data sources used to
ascertain case subjects within the
membership-based center were not
independent.
SEARCH study participants or their
parent/guardian completed a survey
that recorded age, date of diagnosis,
sex, self-reported race/ethnicity, and
place of residence. The study was
reviewed and approved by the
institutional review board(s) at each
center and complied with the privacy
rules established by the Health
Insurance Portability and Accountability
Act. Because this registry attempts to
identify 100% of case subjects, case
subject identification was conducted
with an approved Health Insurance
Portability and Accountability Act
consent waiver in most study locations.
Sources of case reports included
physician reports, medical record
review, or self-report. Case subjects
were considered valid if the medical
record indicated a physician diagnosis,
the diagnosis was verified directly by a
physician, the participant was referred
directly from a physician, or the case
was included in a diabetes database that
had required physician verification,
while eligibility was based on age and
area of residence. Clinical diabetes type
was determined by the physician and
categorized by the study as type 1
diabetes (type 1, type 1a, or type 1b),
type 2 diabetes, or other diabetes
(including other, hybrid, monogenic
diabetes, secondary diabetes, unknown,
and missing type). Cases of gestational
diabetes mellitus were not included in
the study. All case subjects were
registered anonymously with the
coordinating center at Wake Forest
University and included in this report if
they were registered by 31 October
2011.
The numerator for this analysis included
all case subjects prevalent in 2009 who
were aged ,20 years on 31 December
2009, lived in one of the included
geographic areas or were a member of
the KPSC Health Plan or included on the
IHS rolls, and not on active military duty
or living in an institution. Race/
ethnicity, which was by self-report or
extracted from the medical record for
97.3% and estimated using geocoding
for 2.7% (18,19), was classified as non-
Hispanic White (NHW), non-Hispanic
black (black), Hispanic, Asian/Pacific
Islander (ASPI), or American Indian/
Alaskan Native (AIAN).
The denominator included youth
,20 years of age on 31 December
2009 who were noninstitutionalized
civilian residents of the study areas
covered by the geographic centers
or who were members of KPSC
residing in seven counties or who
were enrolled IHS members in 2009.
Derivation of the appropriate
denominators was a multistep process
taking into account racial/ethnicity
categorization and the civilian nature
of the study population (15).
For the four geographic centers, age-,
sex-, and race/ethnicity-specific
denominators were determined using
the 2009 bridged-race intercensal
population estimates released in
October 2012 by the National Center for
Health Statistics (18) and pooled across
centers. The five racial/ethnic groups
listed above were used. The race-
bridging methods developed by the
National Center for Health Statistics
were applied to determine the
probability that a multiracial youth
belongs to each of the four remaining
racial/ethnic groups after excluding the
Hispanics (19). For the KPSC population,
addresses of all members eligible for
inclusion in the study based on age and
geographic location were geocoded to
the census block level. For each
geocoded address, the number of
residents of each group living in that
block was estimated using Census file
SF1 Table P8. The race- and ethnic-
specific proportions were then applied
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to the sex-specific denominator
estimates in 1-year age increments to
estimate the racial and ethnic
composition of youth by age and sex. As
with the geographic-based centers,
race-bridging methods were used. For
AIAN, denominators were based on the
IHS user population, defined as at least
one IHS visit in the previous 3 years.
To derive civilian population
denominators for the geographic
centers, denominators for the youth
aged 17–19 years were adjusted by
subtracting the age-, sex-, racial/ethnic-,
and county-specific number of active-
duty military personnel derived from
the information from theMilitary Family
Resource Center (http://www.mfrc.org)
and the Census Bureau. Racial/ethnic-
specific denominator estimates were
subsequently pooled across all SEARCH
centers.
Statistical Methods
The prevalence of diabetes was
expressed per 1,000 youth using data
pooled across all SEARCH centers. The
95% CIs were calculated using the skew-
corrected inverted score test assuming a
binomial distribution (20,21). To obtain
an estimate of the total number of
youth ,20 years of age with physician-
diagnosed diabetes in theU.S. population,
age-, sex-, and racial/ethnic-specific U.S.
prevalence estimates derived from
SEARCH were applied to the age-, sex-,
and racial/ethnic-specific U.S. population
on the basis of 2009 census population
estimates. For the purposes of
presentation, the standardized rates by
race/ethnicity and four age groups are
shown.
RESULTS
A total of 7,695 youth aged ,20 years
with diabetes of all types was identified
from a population of 3,458,974 youth
(Table 1) for a crude prevalence of 2.22
case subjects/1,000 (95% CI 2.18–2.27).
Total diabetes prevalence increased
with age group from 0.30/1,000 (0.26–
0.33) in those aged ,5 years to 4.03/
1,000 (3.90–4.16) among those aged
15–19 years. Prevalence was highest in
NHW youth (2.70 case subjects/1,000
[95% CI 2.62–2.77]) and lowest in ASPI
youth (0.80 case subjects/1,000 [0.70–
0.92]). Females had a slightly higher
prevalence (2.30 case subjects/1,000
[2.23–2.37]) than males (2.16 case
subjects/1,000 [2.09–2.23]). Of the
7,695 youth with diabetes, 7,505
(97.5%) were identified as having either
type 1 or type 2 diabetes. Of the
remaining 190 case subjects (2.5%),
127 had secondary diabetes, and 63 had
other or unknown type. These case
subjects with a type other than type 1
or type 2 diabetes or with missing
information on type represented a
prevalence of 0.05 case subjects/1,000
(0.05–0.06) (data not shown) and are
excluded from results that follow.
Table 2 shows the prevalence for type 1
and type 2 diabetes overall and by race/
ethnicity. The prevalence of type 1
diabetes was 1.93 case subjects/1,000
(1.88–1.97) and of type 2 diabetes was
0.24 case subjects/1,000 (0.23–0.26).
Type 1 diabetes prevalence was highest
in NHW youth and lowest in AIAN.
Conversely, type 2 diabetes prevalence
was higher in youth from minority race/
ethnic groups than in NHW youth.
Among the 15–19-year-old AIAN, type 2
diabetes accounted for 80.0% of all case
subjects (Fig. 1). Fig. 2 shows the age-
specific prevalence by race/ethnicity
and type. Prevalence rose with
increasing age in all race/ethnic groups
and was highest in the oldest age
groups, except that in AIAN, the
prevalence of type 1 diabetes was
highest at age 10–14 years. The mean
age of onset was 8.1 years for type 1
diabetes and 13.7 years for type 2
diabetes among youth diagnosed with
diabetes before 20 years of age.
The completeness of case
ascertainment for type 1 diabetes in the
four geographic centers was 99.3%
(99.2–99.5%) and was similar by race/
ethnicity and by age group. For type 2
diabetes, in which capture-recapture
was restricted to ages 10–19 years due
to small numbers under the age of 10
years, completeness was slightly lower
at 96.1% (94.6–97.6%) and similar by
race/ethnicity except for Hispanic
youth, in whom it was 90.0% (88.0–
92.0%).
Based on SEARCH-derived prevalence,
;191,986 youth with diabetes aged
,20 years lived in the U.S. in 2009,
including 166,984 with type 1 diabetes
and 20,262 with type 2 diabetes (Table
3). There were ;4,740 secondary,
other, and unknown type of diabetes in
the U.S. in 2009, or 2.5% of all case
subjects identified.
CONCLUSIONS
Based on data from SEARCH, the largest,
most comprehensive surveillance study
of diabetes in U.S. youth to date,
.190,000 youth in the U.S. were
estimated to have physician-diagnosed
diabetes in 2009. This represents ;1 of
every 433 of the ;3.3 million youth
aged ,20 years. This represents an
overall increase in the number of
estimated cases of diabetes of 37,617
between our previously published
estimates for 2001 (15) and 2009. The
increase in the number of case subjects
was primarily driven by an increase in
Table 1—Prevalence of diabetes (all types) in SEARCH by age, race/ethnicity,
and sex, 2009
Number of case subjects Denominator Prevalence/1,000 (95% CI)
Total 7,695 3,458,974 2.22 (2.18–2.27)
Age group
0–4 years 246 832,791 0.30 (0.26–0.33)
5–9 years 1,184 844,923 1.40 (1.32–1.48)
10–14 years 2,580 867,403 2.97 (2.86–3.09)
15–19 years 3,685 913,857 4.03 (3.90–4.16)
Race/ethnicity
NHW 5,085 1,885,451 2.70 (2.62–2.77)
Black 872 383,198 2.28 (2.13–2.43)
Hispanic 1,403 809,267 1.73 (1.65–1.83)
ASPI 210 260,846 0.80 (0.70–0.92)
AIAN 126 120,212 1.05 (0.88–1.24)
Sex
Female 3,886 1,692,112 2.30 (2.23–2.37)
Male 3,809 1,766,862 2.16 (2.09–2.23)
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type 1 diabetes, which increased among
all race/ethnic groups.
Diabetes is one of the leading chronic
diseases in youthdby our estimate,
affecting 2.22/1,000 youth aged ,20
years. Diabetes has a major impact on
public health in this country, costing
;$245 billion in 2012 and shortening
life expectancy for those affected at
young ages (22). The highest net value
of future lost earnings due to premature
death are for youth ,18 years of age
and for young adults between 18 and 34
years of age. The development of
complications is related to the duration
of diabetes, and youth with onset of
diabetes early in life represent a
population at high risk for developing
these complications (23).
Comparisons of prevalence data may be
subject to considerable bias, since
prevalence is determined not only by
disease incidence, but also by case
survival, which may vary across
populations. Prevalence data, however,
are useful in determining the public
health impact of diabetes. In 2011 and
2012, data from the National Survey of
Children’s Health (24), based on
parental self-report, estimated the
prevalence of all types of diabetes
among NHW youth aged ,18 years to
be 4.0 case subjects/1,000, 2.0/1,000 for
Hispanics, 4.0/1,000 for blacks, and 1.0/
1,000 for other race/ethnic groups. This
is similar to our estimate for Hispanics
(1.73/1,000), but is higher than our
estimate for NHW (2.70/1,000) and
black youth (2.28/1,000). However,
those data are based on self-report and
likely to be less reliable than the
validated SEARCH data. A recent
Canadian report on data from 2008 and
2009 suggests somewhat higher
prevalence of diabetes in Canada at 2.0/
1,000 for ages 1–9 years and 5.0/1,000
for ages 10–19 years (25).
Estimates of the prevalence of diabetes
by type have also been reported from
the U.S. state of South Carolina (26) and
the Canadian province ofManitoba (27).
In 1999, type 1 diabetes prevalence in
South Carolina NHWs was 1.1/1,000 at
ages 0–9 years and 2.5/1,000 among
10–19 year olds, somewhat lower than
our results. In Manitoba from 1985–
1993, prevalence of type 1 diabetes
among NHW youth was 0.2/1,000 (age
0–4 years), 1.1/1,000 (age 5–9 years),
and 2.4/1,000 (age 10–14 years), also
lower than we report, likely due to rising
rates of type 1 diabetes.
Type 2 diabetes occurred in youth from
all race/ethnic groups in the SEARCH
cohort. The proportion of type 2
diabetes was lowest in NHW but still
represented 3.5% of all cases of diabetes
in NHW youth. Studies of largely
Caucasian youth in Germany, France,
and the U.K. (28–30) indicate that type 2
diabetes remains rare. The overall
burden of diabetes due to type 2
diabetes in SEARCH increased with age
group in all race/ethnic groups, and,
among 15–19 year olds, type 2 diabetes
was more common than type 1 diabetes
among AIAN youth. These prevalence
figures, while estimating the current
burden of diabetes by type, do not
reflect any changes in proportion of
diabetes types, which can only be
estimated from incidence rates.
The prevalence of type 2 diabetes
has been reported in other studies
largely in minority populations. In
Puerto Rican Hispanics, prevalence
was 0.2/1,000 from age 10–19 years
(31). The differentiation between type 1
and type 2 diabetes was based only on
the use of insulin, likely underestimating
Table 2—Estimates of prevalence in SEARCH/1,000 of diabetes according to diabetes type and race/ethnicity, 2009
Denominator
Type 1 Type 2
Number of case
subjects Prevalence (/1,000) 95% CI
Number of case
subjects Prevalence (/1,000) 95% CI
Race/ethnicity
NHW 1,885,451 4,804 2.55 2.48–2.62 176 0.09 0.08–0.11
Black 383,198 626 1.63 1.51–1.77 214 0.56 0.49–0.64
Hispanic 809,267 1,040 1.29 1.21–1.37 323 0.40 0.36–0.45
ASPI 260,846 156 0.60 0.51–0.70 49 0.19 0.14–0.25
AIAN 120,212 42 0.35 0.26–0.47 75 0.63 0.50–0.79
Total 3,458,974 6,668 1.93 1.88–1.97 837 0.24 0.23–0.26
There were 190 secondary, other, unknown case subjects excluded from Table 2 that are included in Table 1.
Figure 1—Proportion of type 1 and type 2 diabetes among 15–19 year olds in SEARCH by race/ethnicity. Diabetes type other/unknown not included
in figure.
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the type 2 diabetes prevalence, as many
youth with type 2 diabetes are also
treated with insulin (32). The total
prevalence of diabetes (any type) was
0.05/1,000 among .4,000 adolescents
completing self-report information;
44% of these cases were classified as
type 2 diabetes, implying a prevalence
of 0.02/1,000, much lower than the
0.24/1,000 that we report. Possible
factors contributing to differences in
prevalence between studies include
methods of ascertainment and ancestral
region of the Hispanic population. In
SEARCH, the majority of Hispanic
participants’ families are of Mexican
ancestry, rather than Caribbean (33),
which would be likely in a sample from
Puerto Rico.
There are several reports of type 2
diabetes prevalence in American Indian
or First Nations, Canadian populations.
Prevalence in American Indians residing
in Montana, assessed using medical
record review, was 3.5/1,000 (age
10–14 years) but only 0.8/1,000 in youth
aged 15–19 years (34). In First Nations
youth in Canada aged 5–14 years,
prevalence was 7.7/1,000 (35), and was
13.0/1,000 among Oklahoma Cherokees
aged 10–19 years who underwent
screening (36). Among Pima Indians,
who have undergone systematic oral
glucose tolerance testing for many
years, the prevalence in 1987–1996 was
38/1,000 among males aged 15–19
years and 53/1,000 among females (37),
rates much higher than observed in the
American Indian populations in SEARCH
and the highest in theworld. AIAN youth
have the highest prevalence of type 2
diabetes of any race/ethnic group.
There are some limitations to this study.
SEARCH relies on physician diagnosis of
diabetes, identifying only clinically
recognized case subjects reported to or
directly identified by SEARCH sites, so
undiagnosed case subjects are not
included in these prevalence estimates.
For type 1 diabetes, the number of
undiagnosed case subjects is likely very
small, but type 2 diabetes, at least in
adults, can exist for an extended period
of time prior to diagnosis. However,
there is very little undiagnosed diabetes
in youth (38). Some older youth
diagnosed with type 2 diabetes might
not be seeing a physician who is aware
of the SEARCH study, therefore leading
to an underestimation of prevalence in
the older age group. However, this is
likely to have only slight impact based
on our capture-recapture estimates.
Denominator estimates were based on
U.S. Census estimates of the population
in 2009 but corrected for 2010 census
results; however, race/ethnicity was
geocoded for 2.7% of case subjects
using 2010 census data, likely resulting
Figure 2—Prevalence of diabetes in SEARCH/1,000 by type, age group, and race/ethnicity. Diabetes type other/secondary/unknown not included in
figure. Error bars represent 95% CI.
Table 3—Estimated number of youth with diabetes in the U.S. by age group, race/ethnicity, and diabetes type, 2009
Age 0–4 years Age 5–9 years Age 10–14 years Age 15–19 years Total
TotalType 1 Type 2 Type 1 Type 2 Type 1 Type 2 Type 1 Type 2 Type 1 Type 2
Race/ethnicity
NHW 4,192 0 20,317 85 40,866 1,152 54,812 3,187 119,387 4,364 123,751
Black 582 0 3,633 232 7,725 1,542 9,271 5,585 20,887 7,152 28,039
Hispanic 1,028 0 3,917 125 8,517 1,733 9,740 5,289 23,915 7,427 31,342
ASPI 168 0 481 49 832 205 973 506 2,493 779 3,271
AIAN 5 0 59 1 128 97 110 438 303 540 843
Total 5,975 0 28,408 491 58,069 4,729 74,905 15,006 166,984 20,262 187,246
There were ;4,740 secondary, other, and unknown type of diabetes in the U.S. in 2009, or 2.5% of all case subjects identified, resulting in an
estimate of 191,986 persons with diabetes of all types in 2009.
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in some race/ethnicity misclassifications.
Also, the number of AIAN youth was
small, was primarily from IHS rolls in
the Southwest, and may not be
representative of AIAN youth from other
parts of the country or those not using
the IHS. In-person study visits were not
conducted on 2009 prevalent case
subjects, so presence of diabetes
autoantibodies and details of medication
use, obesity, and other risk factors are not
available. However, previous SEARCH
data demonstrated that provider
assessment of diabetes type is a valid
assessment of etiologic diabetes type
(39). The number of participating sites in
SEARCH has changed since 2001 when
the first comprehensive prevalence
survey was conducted (15). A detailed
comparison of changes in prevalence, by
diabetes type, between 2001 and 2009
taking into account the reduced number
of sites will be published separately. Also,
as case ascertainment was based on site/
regional networks, some youth may not
have been identified, particularly those
who are older. Thus, the estimated
prevalence presented in this article is
more likely to be an underestimate in the
upper age group, and thismay explain the
difference between these data and the
higher prevalence observed in older
Canadian youth.
This study also has important strengths.
The population under surveillance by
the SEARCH sites (;3.5 million) has a
similar distribution of important
sociodemographic factors (e.g., race/
ethnicity, parental education, and
income) to the U.S. population as a
whole, suggesting that SEARCH is a
representative sample of U.S. youth at
risk for diabetes (Supplementary Table
1). Thus, these prevalence estimates
should be an accurate representation of
the true number of diagnosed case
subjects in the study areas. This is also
the largest such study of diabetes in
youth in the U.S., making the estimates
for the numbers of case subjects
reasonably precise. The paucity of data
on the prevalence of type 1 diabetes in
contemporary cohorts of youth make
the contribution of the SEARCH study
particularly valuable.
In conclusion, the burden of diabetes in
U.S. youth ,20 years of age in 2009 is
estimated to be 191,986. Of these,
166,984 have type 1 diabetes, and
20,262 have type 2 diabetes. The burden
of type 1 diabetes is highest among
NHW youth and is highest for type 2
diabetes in minority youth, especially
AIAN youth. Efforts are needed both to
provide care for youth living with either
type 1 or type 2 diabetes and to reduce
the risk for development of diabetes and
diabetes-related complications in high-
risk populations.
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